XML 33 R11.htm IDEA: XBRL DOCUMENT v2.4.0.6
Preferred And Common Stock
12 Months Ended
Apr. 30, 2013
Preferred And Common Stock [Abstract]  
Preferred And Common Stock

4.Preferred and Common Stock

 

Preferred stock  The Company has 1,000,000 authorized shares of preferred stock of which 250,000 shares have been designated as Series A Serial Preferred Stock. No shares have been issued.

Common stock  The Company currently has 120,000,000 authorized shares of common stock.

Stock option plans  The 2009 Stock Incentive Plan (the “Plan”), was approved by the Board of Directors in June 2009 and approved by the shareholders in September 2009. The Plan replaced the 2000 Option Plan and the Non-employee Director Stock Plan (together, the “Prior Plans”). There are 4,334,608 shares available for grant at April 30, 2013 under the Plan. Awards made under the Plan may take the form of stock options, restricted stock or restricted stock units. Each share issued pursuant to a stock option will be counted as one share, and each share issued pursuant to an award of restricted stock or restricted stock units will reduce the shares available for grant by two. Additional information regarding the Plan is provided in the Company’s 2009 Proxy Statement. At April 30, 2013, options for 854,809  shares (which expire between 2013 and 2021) were outstanding. All stock option shares issued are previously unissued authorized shares.

On June 23, 2010, restricted stock units with respect to a total of 14,000 shares were granted to the non-employee members of the Board. The fair value of the Company’s shares on the date of grant was $35.94. This award was also granted at no cost to the non-employee members of the Board. This award vested immediately and compensation expense was recognized at that time.

On March 22, 2011, restricted stock units with respect to a total of 14,000 shares were granted to the non-employee members of the Board. The fair value of the Company’s shares on the date of grant was  $36.68. This award was also granted at no cost to the non-employee members of the Board. This award vested on May 1, 2011, and compensation expense was recognized ratably over the vesting period.

On June 10, 2011, restricted stock units with respect to a total of 9,198 shares were granted to certain employees under the annual incentive compensation program. The fair value of the Company’s shares on the date of grant was  $40.49. These awards will vest on May 1, 2014 and compensation expense is being recognized ratably over the vesting period.

On June 23, 2011, stock options totaling 441,000 shares were granted to certain officers and key employees. These awards will vest on June 23, 2014, and compensation expense is being recognized ratably over the vesting period.

On June 23, 2011, restricted stock units totaling 15,000 shares were granted to the CEO. The fair value of the Company’s shares on the date of grant was $44.39.  This award was also granted at no cost to the employee. This award will vest on June 23, 2014 and compensation expense is currently being recognized ratably over the vesting period.

On September 16, 2011, restricted stock units with respect to a total of 14,000 shares were granted to the non-employee members of the Board. The fair value of the Company’s shares on the date of grant was $47.59. This award was also granted at no cost to the non-employee members of the Board. This award vested on May 1, 2012 and compensation expense was recognized ratably over the vesting period.

On June 8, 2012, restricted stock units with respect to a total of 32,998 shares were granted to certain employees under the annual incentive compensation program. The fair value of the Company’s shares on the date of grant was  $59.48. These awards will vest on June 8, 2015 and compensation expense is being recognized ratably over the vesting period.

On September 14, 2012, restricted stock units with respect to a total of 14,000 shares were granted to the non-employee members of the Board. The fair value of the Company’s shares on the date of grant was $58.93.  This award was also granted at no cost to the non-employee members of the Board. This award will vest on May 1, 2013 and compensation expense is currently being recognized ratably over the vesting period.

The 2000 Stock Option Plan allowed the grant of options with an exercise price equal to the fair value of the Company’s stock on the date of grant that expired ten years after the date of grant. Vesting was generally over a three to five-year service period. The Non-employee Directors’ Stock Option Plan allowed the grant of options with an exercise price equal to the average of the last reported sale prices of shares of common stock on the last trading day of each of the twelve months preceding the award of the option. The term of such options was ten years from the date of grant, and each option is exercisable immediately upon grant. The aggregate number of shares of Common Stock that could have been granted pursuant to the Director Stock Plan was 200,000 shares, subject to adjustment to reflect any future stock dividends, stock splits, or other relevant capitalization changes. Shares issued as restricted stock units become unrestricted shares of common stock at the end of the vesting period.

 

 

The following table shows the restricted stock unit and the stock option activity during the periods indicated:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Number of

 

 

 

 

Weighted

 

restricted

 

Number of

 

 

average option

 

stock units

 

option shares

 

 

exercise price

Balance at April 30, 2010

 -

 

959,550 

 

$

22.78

Granted

28,000 

 

 -

 

 

0.00

Exercised

 -

 

(184,441)

 

 

20.24

Forfeited

 -

 

 -

 

 

0.00

Balance at April 30, 2011

28,000 

 

775,109 

 

$

23.38

Granted

38,198 

 

441,000 

 

 

44.39

Exercised

 -

 

(159,600)

 

 

20.36

Forfeited

 -

 

(3,000)

 

 

36.19

Balance at April 30, 2012

66,198 

 

1,053,509 

 

$

32.59

Granted

46,998 

 

 -

 

 

0.00

Exercised

 -

 

(198,200)

 

 

23.82

Forfeited

 -

 

(500)

 

 

14.08

Balance at April 30, 2013

113,196 

 

854,809 

 

$

34.64

 

 

 

 

 

 

 

 

At April 30, 2013, there were 42,000 vested restricted stock units and 71,196 unvested restricted stock units.

At April 30, 2013, all outstanding options had an aggregate intrinsic value of $19,903 and a weighted average remaining contractual life of 6.6 years. The vested options totaled 424,809 shares with a weighted average exercise price of $24.74 per share and a weighted average remaining contractual life of 5.1 years. The aggregate intrinsic value for the vested options as of April 30, 2013 was $14,089. The aggregate intrinsic value for the total of all options exercised during the year ended April 30, 2013 was $6,828, and the total fair value of shares vested during the year ended April 30, 2013 was $2,928.

 The grant date fair value for the June 23, 2011 options were $14.65, which was estimated utilizing the Black Scholes valuation model.  The significant assumptions included:

 

 

 

 

 

Risk-free interest rate

2.14%

Expected option life

6.11 years

Expected volatility

37%

Expected dividend yield

1.58%

 

 

 

Total compensation costs recorded for the years ended April 30, 2013, 2012 and 2011 were $4,270, $3,792, and $2,066, respectively, for the stock option and restricted stock awards. As of April 30, 2013, there was $4,141 of total unrecognized compensation costs related to the Plan and Prior Plans for stock options that are expected to be recognized ratably through 2015.

 

 

At April 30, 2013, the range of exercise prices for outstanding options was $14.08 – $44.39 and the weighted average remaining contractual life of outstanding options was 6.6 years. The number of shares and weighted average remaining contractual life of the options by range of applicable exercise prices at April 30, 2013 were as follows:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Range of

 

Number

 

 

Weighted average

 

Weighted average remaining

 

exercise prices

 

of shares

 

 

exercise price

 

contractual life (years)

 

 

 

 

 

 

 

 

 

$

14.08 - 17.64

 

20,500 

 

$

15.63

 

0.9

 

20.68 - 26.92

 

404,309 

 

 

25.23

 

5.3

 

44.39

 

430,000 

 

 

44.39

 

8.2

 

 

 

854,809